These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 8869815)
1. Sequestered endoplasmic reticulum space for sequential metabolism of salicylamide. Coupling of hydroxylation and glucuronidation. Tirona RG; Pang KS Drug Metab Dispos; 1996 Aug; 24(8):821-33. PubMed ID: 8869815 [TBL] [Abstract][Full Text] [Related]
2. Sequential metabolism of salicylamide exclusively to gentisamide 5-glucuronide and not gentisamide sulfate conjugates in single-pass in situ perfused rat liver. Xu X; Tang BK; Pang KS J Pharmacol Exp Ther; 1990 Jun; 253(3):965-73. PubMed ID: 2359032 [TBL] [Abstract][Full Text] [Related]
3. Hepatic modeling of metabolite kinetics in sequential and parallel pathways: salicylamide and gentisamide metabolism in perfused rat liver. Xu X; Pang KS J Pharmacokinet Biopharm; 1989 Dec; 17(6):645-71. PubMed ID: 2635738 [TBL] [Abstract][Full Text] [Related]
4. Competing pathways in drug metabolism. I. Effect of input concentration on the conjugation of gentisamide in the once-through in situ perfused rat liver preparation. Morris ME; Yuen V; Tang BK; Pang KS J Pharmacol Exp Ther; 1988 May; 245(2):614-24. PubMed ID: 3367309 [TBL] [Abstract][Full Text] [Related]
5. Demonstration of rapid entry and a cellular binding space for salicylamide in perfused rat liver: a multiple indicator dilution study. Pang KS; Barker F; Schwab AJ; Goresky CA J Pharmacol Exp Ther; 1994 Jul; 270(1):285-95. PubMed ID: 8035326 [TBL] [Abstract][Full Text] [Related]
6. First-pass metabolism of salicylamide. Studies in the once-through vascularly perfused rat intestine-liver preparation. Xu X; Hirayama H; Pang KS Drug Metab Dispos; 1989; 17(5):556-63. PubMed ID: 2573500 [TBL] [Abstract][Full Text] [Related]
7. First-pass metabolism of gentisamide: influence of intestinal metabolism on hepatic formation of conjugates. Studies in the once-through vascularly perfused rat intestine-liver preparation. Hirayama H; Pang KS Drug Metab Dispos; 1990; 18(5):580-7. PubMed ID: 1981705 [TBL] [Abstract][Full Text] [Related]
8. Normal and retrograde perfusion to probe the zonal distribution of sulfation and glucuronidation activities of harmol in the perfused rat liver preparation. Pang KS; Koster H; Halsema IC; Scholtens E; Mulder GJ; Stillwell RN J Pharmacol Exp Ther; 1983 Mar; 224(3):647-53. PubMed ID: 6827487 [TBL] [Abstract][Full Text] [Related]
9. Differences in excretion of hippurate, as a metabolite of benzoate and as an administered species, in the single-pass isolated perfused rat kidney explained. Geng W; Pang KS J Pharmacol Exp Ther; 1999 Feb; 288(2):597-606. PubMed ID: 9918564 [TBL] [Abstract][Full Text] [Related]
10. Futile cycling between 4-methylumbelliferone and its conjugates in perfused rat liver. Ratna S; Chiba M; Bandyopadhyay L; Pang KS Hepatology; 1993 May; 17(5):838-53. PubMed ID: 8491453 [TBL] [Abstract][Full Text] [Related]
11. Futile cycling of estrone sulfate and estrone in the recirculating perfused rat liver preparation. Tan E; Lu T; Pang KS J Pharmacol Exp Ther; 2001 Apr; 297(1):423-36. PubMed ID: 11259571 [TBL] [Abstract][Full Text] [Related]
12. Renal handling of enalapril and enalaprilat: studies in the isolated red blood cell-perfused rat kidney. de Lannoy IA; Nespeca R; Pang KS J Pharmacol Exp Ther; 1989 Dec; 251(3):1211-22. PubMed ID: 2557416 [TBL] [Abstract][Full Text] [Related]
13. Dose-dependent bioavailability and metabolism of salicylamide in dogs. Waschek JA; Rubin GM; Tozer TN; Fielding RM; Couet WR; Effeney DJ; Pond SM J Pharmacol Exp Ther; 1984 Jul; 230(1):89-93. PubMed ID: 6747835 [TBL] [Abstract][Full Text] [Related]
14. Alteration of transit time and direction of flow to probe the heterogeneous distribution of conjugating activities for harmol in the perfused rat liver preparation. Dawson JR; Weitering JG; Mulder GJ; Stillwell RN; Pang KS J Pharmacol Exp Ther; 1985 Sep; 234(3):691-7. PubMed ID: 4032287 [TBL] [Abstract][Full Text] [Related]
15. Salicylamide sulfate cell entry in perfused rat liver: a multiple-indicator dilution study. Xu X; Schwab AJ; Barker F; Goresky CA; Pang KS Hepatology; 1994 Jan; 19(1):229-44. PubMed ID: 8276359 [TBL] [Abstract][Full Text] [Related]
16. Moment analysis of metabolic heterogeneity: conjugation of benzoate with glycine in rat liver studied by multiple indicator dilution technique. Schwab AJ; Tao L; Kang M; Meng L; Pang KS J Pharmacol Exp Ther; 2003 Apr; 305(1):279-89. PubMed ID: 12649380 [TBL] [Abstract][Full Text] [Related]
17. Estimations of intestinal and liver first-pass metabolism in vivo. Studies on gentisamide conjugation in the rat. Hirayama H; Morgado J; Gasinska I; Pang KS Drug Metab Dispos; 1990; 18(5):588-94. PubMed ID: 1981706 [TBL] [Abstract][Full Text] [Related]
18. Competing pathways in drug metabolism. II. An identical, anterior enzymic distribution for 2- and 5-sulfoconjugation and a posterior localization for 5-glucuronidation of gentisamide in the rat liver. Morris ME; Yuen V; Pang KS J Pharmacokinet Biopharm; 1988 Dec; 16(6):633-56. PubMed ID: 3251033 [TBL] [Abstract][Full Text] [Related]
19. Carrier-mediated entry of 4-methylumbelliferyl sulfate: characterization by the multiple-indicator dilution technique in perfused rat liver. Chiba M; Schwab AJ; Goresky CA; Pang KS Hepatology; 1998 Jan; 27(1):134-46. PubMed ID: 9425929 [TBL] [Abstract][Full Text] [Related]
20. Nonlinear protein binding and enzyme heterogeneity: effects on hepatic drug removal. Xu X; Selick P; Pang KS J Pharmacokinet Biopharm; 1993 Feb; 21(1):43-74. PubMed ID: 8410683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]